Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study
CZA is an effective and important treatment option for CRKP infection even when it is treated as monotherapy. In patients with impaired renal function, a potential impact of CZA dose adjustments on poor survival outcomes has been observed, indicating the need for further research to determine optimal renal dose adjustment strategies.
Authors
- C.W. Yu (ORCID: https://orcid.org/0009-0002-2485-0416)
- Chun‐Hsing Liao (ORCID: https://orcid.org/0000-0002-4099-3487)
- Chia‐Jui Yang (ORCID: https://orcid.org/0000-0002-5925-2064)
- Mao‐Song Tsai (ORCID: https://orcid.org/0000-0002-8096-3063)
Institutions
- Far Eastern Memorial Hospital (TW)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/idr.s475679
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.34